FanzizFanziz
HomeFinanceCricketSoccerEntertainmentEsports
Menu
HomeFinanceCricketSoccerEntertainmentEsportsWWETennisHealth

Language

AllQuick ReadsFanzShots

Dawaiyon ka review time 90 se 45 din, kya dhamaka hai!

Dawaiyon ka review time 90 se 45 din, kya dhamaka hai!

Arre bhai, suno suno! Union health ministry ne bola hai ki naye dawaon ke liye review time 90 din se 45 din ho gaya hai! Kya baat hai! Ab CDSCO ko sirf inform karna hai, permission nahi leni! High-risk drugs ka kya hoga, samajh nahi aa raha! Lagta hai March tak sab kuch badal jayega, Daya ko bhi khush karne ka mauka milega! Kya dhamaka hai bhai!

Quick rundown

  1. India cuts clinical trial review time by 50%.
  2. New drug approval timeline reduced to 45 days.
  3. CDSCO introduces online application process.
  4. Amendment aims to optimize regulatory resources.
  5. Changes expected to boost drug development efficiency.

Related articles

  • India's Health Ministry Takes Charge on Cough Syrup SalesIndia's Health Ministry Takes Charge on Cough Syrup Sales
  • India Ki Oncology Ka Naya Rang: Precision Medicine Ka Dhamaka!India Ki Oncology Ka Naya Rang: Precision Medicine Ka Dhamaka!
  • India Bans Nimesulide Over 100 mg—Safety First, Folks!India Bans Nimesulide Over 100 mg—Safety First, Folks!
  • Ayushman Bharat Soars: Healthcare Takes Off in 2025!Ayushman Bharat Soars: Healthcare Takes Off in 2025!
  • Nimesulide Banned: Health Ministry Delivers a Knockout!Nimesulide Banned: Health Ministry Delivers a Knockout!

Series

  • Indian Premier League
  • Pakistan Super League
  • South Africa Women tour of New Zealand
  • County Championship Division Two